Stomach Paralysis The FDA has received reports of certain patients using semaglutide, encountering severe gastroparesis, commonly referred toas stomach paralysis. This condition leads to a significant slowing down of food digestion, potentially resulting in intense vomiting and nausea
GLP1 GLP-1-1 GLP1GLP-12 GLP1 GLP-1 GLP-1 BMIkg (m) 2 25 GLP-1 GLP-1 GLP-1GLP-1 15 61012 12 120mL303mg1117mg 1,6501,100 QA 3mg7mg 3mg3mg47mg14mg 2 GLP-1 30 3030 2 GLP-1 2 GLP-1FDA28
They highlight the significance of tracking important metrics like dosage, side effects, protein intake, body composition, and heart rate variability using a dashboard tool, Heads Up, for improved results
A useful benchmark: if you have lost 20 percent or more of starting body weight, if your appetite is well-controlled, and if you are tolerating the current dose without significant GI burden, there is no clinical imperative to escalate further
Endocrinology (2013) 154:142433
This approach is especially beneficial for those with specific health conditions, allergies, or dosage needs that off-the-shelf medications cannot address
